Digging deep into “dirty” drugs – modulation of the methylation machinery

por Pleyer, Lisa, Greil, Richard
Publicado 2015

Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?

por Pleyer, Lisa, Valent, Peter, Greil, Richard
Publicado 2016

IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?

por Leisch, Michael, Greil, Richard, Pleyer, Lisa
Publicado 2020

Reactivation of dormant anti-tumor immunity – a clinical perspective of therapeutic immune checkpoint modulation

por Greil, Richard, Hutterer, Evelyn, Hartmann, Tanja Nicole, Pleyer, Lisa
Publicado 2017

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation

por Wolff, Florian, Leisch, Michael, Greil, Richard, Risch, Angela, Pleyer, Lisa
Publicado 2017

Next Generation Sequencing in AML—On the Way to Becoming a New Standard for Treatment Initiation and/or Modulation?

por Leisch, Michael, Jansko, Bettina, Zaborsky, Nadja, Greil, Richard, Pleyer, Lisa
Publicado 2019

Complications of 5-azacytidine: Three cases of severe ischemic colitis in elderly patients with myelodysplastic syndrome

por MELCHARDT, THOMAS, WEISS, LUKAS, PLEYER, LISA, STEINKIRCHNER, SUSANNE, AUBERGER, JUTTA, HOPFINGER, GEORG, GREIL, RICHARD, EGLE, ALEXANDER
Publicado 2013

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie)

por Huemer, Florian, Thaler, Josef, Piringer, Gudrun, Hackl, Hubert, Pleyer, Lisa, Hufnagl, Clemens, Weiss, Lukas, Greil, Richard
Publicado 2018

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

por Greil, Richard, Pleyer, Lisa, Jansko, Bettina, Feierabend, Carmen, Rettenbacher, Lukas, Stiefel, Olga, Rass, Christoph, Morre, Patrick, Neureiter, Daniel, Greil-Ressler, Sigrun
Publicado 2018

Functionally distinct promoter classes initiate transcription via different mechanisms reflected in focused versus dispersed initiation patterns

por Serebreni, Leonid, Pleyer, Lisa‐Marie, Haberle, Vanja, Hendy, Oliver, Vlasova, Anna, Loubiere, Vincent, Nemčko, Filip, Bergauer, Katharina, Roitinger, Elisabeth, Mechtler, Karl, Stark, Alexander
Publicado 2023

Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group

por Jansko-Gadermeir, Bettina, Leisch, Michael, Gassner, Franz J., Zaborsky, Nadja, Dillinger, Thomas, Hutter, Sonja, Risch, Angela, Melchardt, Thomas, Egle, Alexander, Drost, Manuel, Larcher-Senn, Julian, Greil, Richard, Pleyer, Lisa
Publicado 2023

S174: MYELOID NGS ANALYSES OF PAIRED SAMPLES FROM BONE MARROW AND PERIPHERAL BLOOD YIELD CONCORDANT RESULTS: A PROSPECTIVE COHORT ANALYSIS OF THE AGMT STUDY GROUP

por Pleyer, Lisa, Jansko-Gadermeir, Bettina, Gassner, Franz J., Leisch, Michael, Wagner, Jakob, Zaborsky, Nadja, Dillinger, Thomas, Hutter, Sonja, Melchardt, Thomas, Egle, Alexander, Drost, Manuel, Larcher-Senn, Julian, Greil, Richard
Publicado 2023

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia

por Catakovic, Kemal, Gassner, Franz Josef, Ratswohl, Christoph, Zaborsky, Nadja, Rebhandl, Stefan, Schubert, Maria, Steiner, Markus, Gutjahr, Julia Christine, Pleyer, Lisa, Egle, Alexander, Hartmann, Tanja Nicole, Greil, Richard, Geisberger, Roland
Publicado 2017

Supervised versus autonomous exercise training in breast cancer patients: A multicenter randomized clinical trial

por Westphal, Theresa, Rinnerthaler, Gabriel, Gampenrieder, Simon Peter, Niebauer, Josef, Thaler, Josef, Pfob, Michael, Fuchs, David, Riedmann, Marina, Mayr, Barbara, Reich, Bernhard, Melchardt, Thomas, Mlineritsch, Brigitte, Pleyer, Lisa, Greil, Richard
Publicado 2018

Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL‐2 and/or BIM

por Huemer, Florian, Melchardt, Thomas, Jansko, Bettina, Wahida, Adam, Jilg, Stefanie, Jost, Philipp J., Klieser, Eckhard, Steiger, Katja, Magnes, Teresa, Pleyer, Lisa, Greil‐Ressler, Sigrun, Rass, Christof, Greil, Richard, Egle, Alexander
Publicado 2019

Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVL...

por Egle, Alexander, Steurer, Michael, Melchardt, Thomas, Weiss, Lukas, Gassner, Franz Josef, Zaborsky, Nadja, Geisberger, Roland, Catakovic, Kemal, Hartmann, Tanja Nicole, Pleyer, Lisa, Voskova, Daniela, Thaler, Josef, Lang, Alois, Girschikofsky, Michael, Petzer, Andreas, Greil, Richard
Publicado 2018

Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group

por Pleyer, Lisa, Stauder, Reinhard, Burgstaller, Sonja, Schreder, Martin, Tinchon, Christoph, Pfeilstocker, Michael, Steinkirchner, Susanne, Melchardt, Thomas, Mitrovic, Martina, Girschikofsky, Michael, Lang, Alois, Krippl, Peter, Sliwa, Thamer, Egle, Alexander, Linkesch, Werner, Voskova, Daniela, Angermann, Hubert, Greil, Richard
Publicado 2013

Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia

por Huemer, Florian, Weiss, Lukas, Faber, Viktoria, Neureiter, Daniel, Egle, Alexander, Geissler, Klaus, Voskova, Daniela, Zebisch, Armin, Burgstaller, Sonja, Pichler, Angelika, Stauder, Reinhard, Sperr, Wolfgang, Lang, Alois, Pfeilstöcker, Michael, Machherndl-Spandl, Sigrid, Stampfl, Margarete, Greil, Richard, Pleyer, Lisa
Publicado 2018

Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group

por Pleyer, Lisa, Burgstaller, Sonja, Girschikofsky, Michael, Linkesch, Werner, Stauder, Reinhard, Pfeilstocker, Michael, Schreder, Martin, Tinchon, Christoph, Sliwa, Thamer, Lang, Alois, Sperr, Wolfgang R., Krippl, Peter, Geissler, Dietmar, Voskova, Daniela, Schlick, Konstantin, Thaler, Josef, Machherndl-Spandl, Sigrid, Theiler, Georg, Eckmüllner, Otto, Greil, Richard
Publicado 2014

The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells

por Urwanisch, Laura, Unger, Michael Stefan, Sieberer, Helene, Dang, Hieu-Hoa, Neuper, Theresa, Regl, Christof, Vetter, Julia, Schaller, Susanne, Winkler, Stephan M., Kerschbamer, Emanuela, Weichenberger, Christian X., Krenn, Peter W., Luciano, Michela, Pleyer, Lisa, Greil, Richard, Huber, Christian G., Aberger, Fritz, Horejs-Hoeck, Jutta
Publicado 2023